Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
131,906,059
-
Number of holders
-
58
-
Total 13F shares, excl. options
-
38,559,195
-
Shares change
-
+1,372,466
-
Total reported value, excl. options
-
$71,717,529
-
Value change
-
+$2,582,813
-
Number of buys
-
19
-
Number of sells
-
26
-
Price
-
$1.86
Institutional Holders of Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (OVID) as of Q4 2022
As of 31 Dec 2022 Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (OVID) had 68 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 38,559,195 shares of stock of the company.
Largest 10 holders included BVF INC/IL, Rubric Capital Management LP, EcoR1 Capital, LLC, Madison Avenue Partners, LP, VANGUARD GROUP INC, Artal Group S.A., ACADIAN ASSET MANAGEMENT LLC, TLS Advisors LLC, DRIEHAUS CAPITAL MANAGEMENT LLC, and BRIDGEWAY CAPITAL MANAGEMENT, LLC.
This table shows 68 institutional shareholders of the security as of 31 Dec 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.